Ecolab Inc. ECL
Composite 46/100; the shares have moved about 24% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 25/100 — a strong mark against it.
Quality ranks 60/100 — a slight point in its favour. Balance-sheet strength ranks 52/100 — a slight point in its favour. Momentum ranks 51/100 — a slight point in its favour.
Valuation ranks 25/100 — a strong mark against it. Growth ranks 40/100 — a slight mark against it. Income ranks 47/100 — a slight mark against it.
What the company does Ecolab Inc. (ECL) provides water, hygiene, and infection prevention solutions across Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences segments. Its offerings serve manufacturing, food and beverage, healthcare, hospitality, and industrial sectors globally.
Key financials ECL reports ROE 22%, ROA 7.2%, and net margins 12.6%. Revenue grew 9.7% while EPS grew 3.3%. Gross margins stand at 44.2% with operating margins at 18.2%. Debt/Equity is 1.36 and current ratio is 1.84.
Stock health The stock shows mixed momentum: +11.10% over 3 months, +1.63% over 6 months, and +9.17% over 12 months. It is down 7.20% from its 52-week high, with RSI(14) at 62.10. Sideravia scores Quality 57.4 and Momentum 54.3, indicating average quality with moderate momentum.
Price vs fair value The stock trades at a **discount of 13.70%** to the analyst mean target of 324.67. - Forward P/E of 34.72 and PEG of 3.33 suggest valuation richness (Sideravia). - High P/E 38.34 and EV/EBITDA 22.60 reflect premium pricing (Sideravia). - Recent earnings misses by peers (e.g., International Flavors Q2) may weigh on sentiment (Zacks).
Looking forward Forward P/E of 34.72 and PEG of 3.33 imply expectations for sustained growth but at a premium. Analysts’ mean target suggests potential upside, though current multiples and margins warrant monitoring for execution risks.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.